Editors' Note: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

被引：0
|
作者：
Galetta, Steven
Ganesh, Aravind
Lewis, Ariane
Siegler, James E., III
机构：
来源：
NEUROLOGY | 2022年 / 99卷 / 06期
关键词：
D O I：
10.1212/WNL.0000000000201001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：258 / 258
页数：1
相关论文
共 33 条
  • [31] Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5
    Parker, Maria a.
    Erker, Laura r.
    Audo, I. S. A. B. E. L. L. E.
    Choi, D. O. N. G. S. E. O. K.
    Mohand-said, S. A. D. D. E. K.
    Sestakauskas, K. A. S. T. Y. T. I. S.
    Benoit, P. A. T. R. I. C. K.
    Appelqvist, T. E. R. E. N. C. E.
    Krahmer, M. E. L. I. S. S. A.
    Segaut-prevost, C. A. R. O. L. I. N. E.
    Lujan, Brandon j.
    Faridi, A. M. B. A. R.
    Chegarnov, Elvira n.
    Steinkamp, Peter n.
    Ku, C. R. I. S. T. Y.
    Palma, Mariana matioli da
    Barale, Pierre-olivier
    Ayelo-scheer, S. A. R. A. H.
    Lauer, A. N. D. R. E. A. S.
    Stout, T. I. M.
    Wilson, David j.
    Weleber, Richard g.
    Pennesi, Mark e.
    Sahel, JOSe A. L. A. I. N.
    Yang, P. A. U. L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 240 : 285 - 301
  • [32] Phase 1/2 Open-label Dose Evaluation Study of AXO-Lenti-PD Gene Therapy for Parkinson's Disease: Efficacy, Safety, and Tolerability Data from the Second Cohort at 6 Months
    Corcoran, G.
    Karunakara, A.
    Vaughn, B.
    Brand-Schieber, E.
    Foltynie, T.
    Barker, R.
    Palfi, S.
    MOVEMENT DISORDERS, 2021, 36 : S167 - S167
  • [33] Sustained Efficacy and Safety at Week 52 and Up to Three Years in Adults with Glycogen Storage Disease Type iA (GSDIa): Results from a Phase 1/2 Clinical Trial of DTX401, an AAV8-mediated, Liver-Directed Gene Therapy
    Riba-Wolman, Rebecca
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Pico, Maria-Luz Couce
    Derks, Terry G.
    Mitchell, John
    Weinstein, David A.
    Mitragotri, Deepali
    Valayannopoulos, Vassili
    Crombez, Eric
    MOLECULAR THERAPY, 2022, 30 (04) : 564 - 564
1234